Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Share-based Compensation (2016 - 2025)

Traws Pharma's Share-based Compensation history spans 14 years, with the latest figure at $327000.0 for Q4 2025.

  • Quarterly results put Share-based Compensation at $327000.0 for Q4 2025, down 2.1% from a year ago — trailing twelve months through Dec 2025 was $728000.0 (down 47.63% YoY), and the annual figure for FY2025 was $728000.0, down 47.63%.
  • Share-based Compensation for Q4 2025 was $327000.0 at Traws Pharma, up from $135000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $380000.0 in Q2 2024 to a low of $60000.0 in Q2 2021.
  • The 5-year median for Share-based Compensation is $292500.0 (2022), against an average of $257150.0.
  • The sharpest move saw Share-based Compensation skyrocketed 355.38% in 2022, then plummeted 72.37% in 2025.
  • Year by year, Share-based Compensation stood at $261000.0 in 2021, then increased by 26.44% to $330000.0 in 2022, then rose by 0.61% to $332000.0 in 2023, then rose by 0.6% to $334000.0 in 2024, then dropped by 2.1% to $327000.0 in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $327000.0, $135000.0, and $105000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.